Oaktree Acquisition III Life Sciences Revenue 2025-2024 | OACC
Oaktree Acquisition III Life Sciences revenue from 2025 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Oaktree Acquisition III Life Sciences Annual Revenue (Millions of US $) |
|---|
| Oaktree Acquisition III Life Sciences Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | |
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Flowco Holdings (FLOC) | United States | $1.815B | 0.00 |
| Range Capital Acquisition (RANG) | United States | $0.141B | 0.00 |
| Tavia Acquisition (TAVI) | $0.140B | 0.00 | |
| Aduro Clean Technologies (ADUR) | Canada | $0.126B | 0.00 |
| YSX Tech (YSXT) | China | $0.101B | 0.00 |
| CO2 Energy Transition (NOEM) | United States | $0.096B | 0.00 |
| Leishen Energy Holding (LSE) | China | $0.091B | 0.00 |
| YHN Acquisition I (YHNA) | $0.082B | 0.00 | |
| Youxin Technology (YAAS) | $0.043B | 0.00 | |
| New Century Logistics (BVI) (NCEW) | Hong Kong, SAR China | $0.037B | 0.00 |
| Sky Quarry (SKYQ) | United States | $0.016B | 0.00 |
| PicoCELA (PCLA) | Japan | $0.012B | 0.00 |
| Hong Kong Pharma Digital Technology Holdings (HKPD) | $0.010B | 0.00 |